Table 1.
Antibody profile of the study population
| Variable | Incidence (n=20) |
|---|---|
| Anticardiolipin antibody positive | 11 |
| β2 Glycoprotein1 antibody positive | 5 |
| Lupus anticoagulant positive | 10 |
| Double positive | 4 |
| Triple positive | 2 |
Some participants tested positive for more than one aPL test.
Double positive – any 2 of 3 above (aCL, B2GP1, LAC) testing positive in the same individual; Triple positive – all 3 testing positive in the same individual.